Acknowledging Lung Cancer in Women as a Distinct and Underserved Malignancy – Lung Cancer Europe
Abdu Adem Yesufe/ oncodaily.com

Acknowledging Lung Cancer in Women as a Distinct and Underserved Malignancy – Lung Cancer Europe

Abdu Adem Yesufe, Program Director of Adult Hematology and Medical Oncology Fellowship at St. Paul’s Hospital Millennium Medical College (SPHMMC), shared a post by Lung Cancer Europe, on LinkedIn, adding:

A grave reality of our mothers and sisters, indoor smoke exposure/unintentional smoking, leading to widespread cases and deaths from Lung cancer!”

Quoting Lung Cancer Europe‘s post:

”This week, Nature declared it. Lung cancer in women is a distinct disease.

A malignancy once understood primarily through the lens of men who smoked now looks very different. Younger. Female. Often never-smoker. Driven by distinct biology. And still being missed by the systems designed to find it.

At ASCO 2026 last week, the evidence was everywhere. Lung cancer incidence rising sharply in younger women. Screening criteria built on male data that exclude women at genuine risk. A plenary trial where only 7% of participants were female.

Dr Narjust Florez FASCO has been a tireless champion of this agenda for years. This moment reflects her work and the work of many others who refused to let this be overlooked.

We are only beginning to understand what this means for research, clinical practice, and policy. But the conversation is overdue.”

Acknowledging Lung Cancer in Women as a Distinct and Underserved Malignancy - Lung Cancer Europe

Other Articles Featuring Abdu Adem Yesufe and Lung Cancer Europe on OncoDaily.